By Karlee Weinmann ( May 12, 2014, 10:57 AM EDT) -- Allergan Inc. on Monday rejected an unsolicited takeover offer worth about $46 billion from Valeant Pharmaceuticals Inc. and activist investor Bill Ackman, setting the stage for a high-profile and contentious fight for control of the California-based Botox maker....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.